SPYRE THERAPEUTICS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SPYRE THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-06-30 was $0.00.
- SPYRE THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $0.00.
- SPYRE THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-09-30 was -$8.00K.
- SPYRE THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $0.00.
- SPYRE THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2016 was $58.31M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $0.00 10-K · filed 2026-02-19 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-11-04 | |
| 2022-09-30 | -$8.00K 10-Q · filed 2023-11-09 | |
| 2016-12-31 | $58.31M 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |